KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Cash & Equivalents (2016 - 2026)

Silicon Laboratories has reported Cash & Equivalents over the past 18 years, most recently at $364.2 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 29.34% year-over-year to $364.2 million; the TTM value through Jan 2026 reached $364.2 million, up 29.34%, while the annual FY2026 figure was $364.2 million, 29.34% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $364.2 million at Silicon Laboratories, up from $341.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.1 billion in Q1 2022 and troughed at $159.9 million in Q3 2023.
  • A 5-year average of $413.5 million and a median of $324.9 million in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 430.1% in 2022 and later plummeted 73.27% in 2024.
  • Year by year, Cash & Equivalents stood at $499.9 million in 2022, then crashed by 54.49% to $227.5 million in 2023, then increased by 23.78% to $281.6 million in 2024, then rose by 21.23% to $341.4 million in 2025, then rose by 6.68% to $364.2 million in 2026.
  • Business Quant data shows Cash & Equivalents for SLAB at $364.2 million in Q1 2026, $341.4 million in Q4 2025, and $314.5 million in Q3 2025.